Indiana § 16-42-23-1 Health care facilities; restrictions on use

Indiana Statutes

§ 16-42-23-1 — Health care facilities; restrictions on use

Indiana § 16-42-23-1

Title 16HEALTH

Art. 42REGULATION OF FOOD, DRUGS, AND

Ch. 23Drugs: Use of Amygdalin (Laetrile)

This text of Indiana § 16-42-23-1 (Health care facilities; restrictions on use) is published on Counsel Stack Legal Research, covering Indiana primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Ind. Code § 16-42-23-1 (2026).

Text

Except as provided in section 8 of this chapter, a hospital or other health care facility may not interfere with the physician-patient relationship by restricting or forbidding the use of amygdalin (laetrile) as an adjunct to recognized, customary, or accepted modes of therapy in the treatment of any malignancy, disease, illness, or physical condition if the following conditions exist:

(1)Amygdalin (laetrile) is prescribed or administered by a physician holding an unlimited license for the practice of medicine in Indiana.

(2)The patient has signed the "written informed request" as set forth in section 5 of this chapter. [Pre-1993 Recodification Citation: 16-8-8-1.]

Free access — add to your briefcase to read the full text and ask questions with AI

Except as provided in section 8 of this
chapter, a hospital or other health care facility may not interfere with
the physician-patient relationship by restricting or forbidding the use
of amygdalin (laetrile) as an adjunct to recognized, customary, or
accepted modes of therapy in the treatment of any malignancy, disease,
illness, or physical condition if the following conditions exist:
(1) Amygdalin (laetrile) is prescribed or administered by a
physician holding an unlimited license for the practice of
medicine in Indiana.
(2) The patient has signed the "written informed request" as set
forth in section 5 of this chapter.
[Pre-1993 Recodification Citation: 16-8-8-1.]